Furthermore, those components that regulate the cell cycle could be the novel targets for the development of an effective pituitary adenoma therapy; for example, the proteasome inhibitors can induce apoptosis in growth hormone-and prolactin-secreting rat pituitary tumor cells through a blocking of the cell cycle at the G2/M transition [69]. The gene discussed is PRL; the disease is pituitary gland adenoma.